These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 20599486

  • 1. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
    Na L, Mao S, Wang J, Sun W.
    Int J Pharm; 2010 Sep 15; 397(1-2):59-66. PubMed ID: 20599486
    [Abstract] [Full Text] [Related]

  • 2. A novel permeation enhancer: N-succinyl chitosan on the intranasal absorption of isosorbide dinitrate in rats.
    Na L, Wang J, Wang L, Mao S.
    Eur J Pharm Sci; 2013 Jan 23; 48(1-2):301-6. PubMed ID: 23159664
    [Abstract] [Full Text] [Related]

  • 3. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
    Mei D, Mao S, Sun W, Wang Y, Kissel T.
    Eur J Pharm Biopharm; 2008 Nov 23; 70(3):874-81. PubMed ID: 18656537
    [Abstract] [Full Text] [Related]

  • 4. Non-ionic surfactants as novel intranasal absorption enhancers: in vitro and in vivo characterization.
    Li Y, Li J, Zhang X, Ding J, Mao S.
    Drug Deliv; 2016 Sep 23; 23(7):2272-2279. PubMed ID: 25347689
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ, Ma CH, Lu WL, Zhang X, Wang XL, Sun JN, Zhang Q.
    Acta Pharmacol Sin; 2005 Nov 23; 26(11):1402-8. PubMed ID: 16225765
    [Abstract] [Full Text] [Related]

  • 7. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system.
    Gabiga H, Cal K, Janicki S.
    Int J Pharm; 2000 Apr 10; 199(1):1-6. PubMed ID: 10794921
    [Abstract] [Full Text] [Related]

  • 8. The influence of absorption enhancers on nasal absorption of acyclovir.
    Chavanpatil MD, Vavia PR.
    Eur J Pharm Biopharm; 2004 May 10; 57(3):483-7. PubMed ID: 15093597
    [Abstract] [Full Text] [Related]

  • 9. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM, Awad GA, Mortada ND, Abd ElHady SS.
    Int J Pharm; 2006 Dec 11; 327(1-2):89-96. PubMed ID: 16942844
    [Abstract] [Full Text] [Related]

  • 10. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
    Sinswat P, Tengamnuay P.
    Int J Pharm; 2003 May 12; 257(1-2):15-22. PubMed ID: 12711157
    [Abstract] [Full Text] [Related]

  • 11. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S, Patil K, Yeole P, Gaikwad R.
    J Pharm Pharmacol; 2009 May 12; 61(5):669-75. PubMed ID: 19406007
    [Abstract] [Full Text] [Related]

  • 12. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH, Fu JH, Wang SM, Su CH, Shan Y, Kong SJ, Wang Y, Lu WL, Zhang H, Zhang S, Li L, Zhang EH, Wang L, Pei QL, Wang JC, Zhang X, Zhang Q.
    Int J Pharm; 2007 Jun 07; 337(1-2):88-101. PubMed ID: 17267147
    [Abstract] [Full Text] [Related]

  • 13. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
    Tengamnuay P, Sahamethapat A, Sailasuta A, Mitra AK.
    Int J Pharm; 2000 Mar 20; 197(1-2):53-67. PubMed ID: 10704793
    [Abstract] [Full Text] [Related]

  • 14. [Effect of absorption enhancers on nasal ginsenoside Rg1 delivery and its nasal ciliotoxicity].
    Chen XM, Zhu JB, Sun WD, Zhang LJ.
    Yao Xue Xue Bao; 2006 Feb 20; 41(2):149-55. PubMed ID: 16671546
    [Abstract] [Full Text] [Related]

  • 15. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM, Mortada ND, Awad GA, Abd ElHady SS.
    Int J Pharm; 2006 Dec 11; 327(1-2):97-103. PubMed ID: 16959453
    [Abstract] [Full Text] [Related]

  • 16. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
    Zhang Y, Jiang XG, Yao J.
    Acta Pharmacol Sin; 2001 Nov 11; 22(11):1051-6. PubMed ID: 11749800
    [Abstract] [Full Text] [Related]

  • 17. The in situ and in vivo study on enhancing effect of borneol in nasal absorption of Geniposide in rats.
    Lu Y, Chen X, Du S, Wu Q, Yao Z, Zhai Y.
    Arch Pharm Res; 2010 May 11; 33(5):691-6. PubMed ID: 20512466
    [Abstract] [Full Text] [Related]

  • 18. Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
    Khan SA, Patil KS, Yeole PG.
    Pharmazie; 2008 May 11; 63(5):348-51. PubMed ID: 18557417
    [Abstract] [Full Text] [Related]

  • 19. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
    Marttin E, Verhoef JC, Merkus FW.
    J Drug Target; 1998 May 11; 6(1):17-36. PubMed ID: 9769018
    [Abstract] [Full Text] [Related]

  • 20. Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration.
    Xia Y, Li L, Huang X, Wang Z, Zhang H, Gao J, Du Y, Chen W, Zheng A.
    Drug Dev Ind Pharm; 2020 May 11; 46(5):697-705. PubMed ID: 32293206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.